<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17033" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Abetalipoproteinemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Junaid</surname>
            <given-names>Syeda Zeenat S.</given-names>
          </name>
          <aff>Bahria Medical College, Pakistan</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Krunal</given-names>
          </name>
          <aff>Louisiana State University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Syeda Zeenat Junaid declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Krunal Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17033.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Abetalipoproteinemia is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins, and very-low-density lipoproteins. It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include fat malabsorption, spinocerebellar degeneration, acanthocytosis, and retinitis pigmentosa. This activity reviews the etiology, epidemiology, pathophysiology, evaluation, and treatment considerations of this disease and highlights the role of the collaboration between interprofessional team members.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Explain how abetalipoproteinemia manifests in each of the three main organ systems that it affects.</p></list-item><list-item><p>Describe anticipated laboratory findings of a patient with abetalipoproteinemia.</p></list-item><list-item><p>Outline the treatment of abetalipoproteinemia.</p></list-item><list-item><p>Review the importance of collaboration between interprofessional team members for improved recognition and treatment of abetalipoproteinemia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17033&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17033">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17033.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Abetalipoproteinemia (ABL)&#x000a0;is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins (LDLs), and very-low-density lipoproteins (VLDLs). It should not be confused with a deficiency in beta-lipoproteins. Hallmark symptoms include&#x000a0;fat malabsorption, spinocerebellar degeneration, acanthocyte red blood cells, and retinitis pigmentosa.&#x000a0;<xref ref-type="bibr" rid="article-17033.r1">[1]</xref><xref ref-type="bibr" rid="article-17033.r2">[2]</xref></p>
        <p>Treatment aims to arrest the neuropathy and efficiency-induced complications in patients.</p>
      </sec>
      <sec id="article-17033.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Abetalipoproteinemia is caused by a homozygous autosomal recessive mutation in the <italic toggle="yes">MTTP</italic> gene. More than 33 mutations that cause the disease have been identified. The gene codes for microsomal triglyceride protein&#x000a0;(MTP) that mediates intracellular chylomicron or VLDL assembly and transport in the intestinal mucosa and hepatocytes.&#x000a0;Most of the signs and symptoms of the disease result from a severe deficiency of fats and fat-soluble vitamins, especially vitamin E. It usually presents in infants as failure to thrive, steatorrhea, and abdominal distension and results in spinocerebellar degeneration and retinitis pigmentosa.<xref ref-type="bibr" rid="article-17033.r3">[3]</xref></p>
      </sec>
      <sec id="article-17033.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Abetalipoproteinemia occurs in less than 1 in 1 million persons. Consanguineous marriages are strongly implicated. Because it is autosomal recessive,&#x000a0;both copies of the gene must be faulty to cause the disease. It occurs&#x000a0;in females and males equally.&#x000a0;<xref ref-type="bibr" rid="article-17033.r4">[4]</xref></p>
        <p>One particular mutation is more common in people of Ashkenazi (eastern and central European) Jewish descent. This mutation substitutes the protein building block, or amino acid, glycine with a stop signal at position 865 (written as Gly865X or G865X). As a result of this amino acid change, an abnormally small, nonfunctional version of the protein is made.&#x000a0;<xref ref-type="bibr" rid="article-17033.r5">[5]</xref></p>
      </sec>
      <sec id="article-17033.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Beta apolipoproteins are very large apolipoproteins. They are critically important for the secretion and formation of chylomicrons (CMs) and VLDL. Abnormalities that impede this process result in abetalipoproteinemia and hypobetalipoproteinemia.&#x000a0;<xref ref-type="bibr" rid="article-17033.r6">[6]</xref><xref ref-type="bibr" rid="article-17033.r7">[7]</xref><xref ref-type="bibr" rid="article-17033.r8">[8]</xref></p>
        <p>MTP acts as a chaperone that facilitates the transfer of lipids onto apo B. MTP is found within the lumen of microsomes in the liver and intestinal mucosa and&#x000a0;catalyzes the transfer of triglyceride, cholesteryl esters, and phosphatidylcholine between membranes.&#x000a0;Lipid transport rates decrease in the order of triglyceride to cholesteryl ester to diglyceride to cholesterol to phosphatidylcholine. Unlike other lipid transfer proteins, MTP is a heterodimer containing subunits of molecular mass 58 and 97 kDa. The large 97-kDa subunit possesses the lipid transfer activity or confers lipid transfer activity on the complex. The large subunit of MTP may be missing in abetalipoproteinemia.</p>
        <p>Initial assembly occurs in the endoplasmic reticulum, where apolipoproteins, cholesterol, phospholipid, and triacylglycerides are synthesized and incorporated into lipoprotein particles. The particles are subsequently transported to Golgi and secreted.&#x000a0;Each lipoprotein is specific in its lipid composition and the type of apolipoproteins it possesses.</p>
        <p>The two beta apolipoproteins are B-100 and B-48. ApoB-100 is carried on VLDL. ApoB-100, synthesized by the liver, is larger than apoB-48, which is made up of 4536 amino acids. Unlike apoB-48, apoB-100 contains the binding site essential for LDL uptake by hepatocyte LDL receptors. ApoB-48 is carried on CMs and is derived from the same gene as apoB-100.<xref ref-type="bibr" rid="article-17033.r1">[1]</xref>&#x000a0;</p>
        <p>
<bold>Gastrointestinal Manifestations</bold>
</p>
        <p>These manifestations include diarrhea and fat-soluble vitamin deficiency. They are evident from infancy.&#x000a0;Diarrhea may not be a prominent symptom later, though, because patients learn to avoid fatty foods. However, the&#x000a0;deficits in&#x000a0;fat-soluble vitamins continue because their assimilation and transport depend heavily on&#x000a0;the integrity of the&#x000a0;apoB pathway. It is worth noting that high-dose vitamin E supplementation only results in marginally increased serum vitamin levels. In contrast,&#x000a0;high doses of vitamin-A therapy can achieve normal serum levels. This shows that despite the damaged intestinal&#x000a0;absorption, the transport of vitamin A by retinol-binding proteins in serum is not impaired in abetalipoproteinemia.</p>
        <p>
<bold>Hepatic Manifestations</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hepatomegaly due to hepatic steatosis.</p>
          </list-item>
          <list-item>
            <p>Possible increase in serum ALTs and ASTs</p>
          </list-item>
          <list-item>
            <p>Reports of cirrhosis&#x000a0;in some patients</p>
          </list-item>
        </list>
        <p>
<bold>Hematologic Manifestations</bold>
</p>
        <p>Acanthocytosis is a hallmark feature of this disease. Acanthocytes are abnormally spiked RBCs due to the defective phospholipid cell membrane. They are also seen in liver dysfunction. Because of their inability to form rouleaux, erythrocyte sedimentation rates could be very&#x000a0;low. Fat malabsorption could lead to deficiencies in iron, and folic acid, among others, and lead to anemia. Vitamin E is involved in protection from free radical damage. Its deficiency could potentiate lipid peroxidation of cells and lead to hemolysis. This exacerbates anemia. Vitamin K is involved in the gamma decarboxylation of clotting factors, an indispensable step in coagulation. Its deficiency could lead to bleeding disorders.</p>
        <p>
<bold>Neurological Involvement</bold>
</p>
        <p>Peripheral neuropathy, delayed intellectual development, tremor, nystagmus, loss of deep tendon reflexes</p>
        <p>These may be myriad and variable in their severity. The primary pathophysiology is demyelination due to deficiency of lipid-soluble vitamins. The central and peripheral nervous systems are both affected.</p>
        <p>
<bold>Muscle Involvement</bold>
</p>
        <p>Weakness and increased degeneration</p>
        <p>
<bold>Ophthalmic Involvement</bold>
</p>
        <p>Retinitis pigmentosa, decreased night and color vision, blindness</p>
      </sec>
      <sec id="article-17033.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Acanthocytes on the peripheral blood smear are seen in&#x000a0;abetalipoproteinemia.</p>
      </sec>
      <sec id="article-17033.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Failure to thrive in infancy may cause gastroenterologic, neurologic, and ophthalmologic&#x000a0;symptoms, including&#x000a0;the following:</p>
        <p>
<bold>Gastroenterology Symptoms</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Steatorrhea and diarrhea&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Abdominal distension</p>
          </list-item>
        </list>
        <p>
<bold>Neurologic Symptoms&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Slow mental growth</p>
          </list-item>
          <list-item>
            <p>Deep tendon reflexes are absent</p>
          </list-item>
          <list-item>
            <p>Ataxia</p>
          </list-item>
          <list-item>
            <p>Slurred speech</p>
          </list-item>
          <list-item>
            <p>Peripheral neuropathy.</p>
          </list-item>
          <list-item>
            <p>Intention tremors.</p>
          </list-item>
        </list>
        <p>
<bold>Ophthalmologic Symptoms</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Retinitis pigmentosa&#x000a0;by adolescence (due to deficiency of vitamin A)</p>
          </list-item>
          <list-item>
            <p>Decreased night and color vision.</p>
          </list-item>
          <list-item>
            <p>Blindness may occur</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17033.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Complete Blood Count</bold>
</p>
        <p>Complete blood count shows anemia, thrombocytopenia, or pancytopenia.<xref ref-type="bibr" rid="article-17033.r1">[1]</xref></p>
        <p>
<bold>Blood Smear</bold>
</p>
        <p>Blood smear shows acanthocytes (Burr cells).</p>
        <p>
<bold>Fasting Lipid Profile</bold>
</p>
        <p>Fasting lipid profile shows low VLDLs, LDLs, and total cholesterol.</p>
        <p>
<bold>Stool Study</bold>
</p>
        <p>Stool studies show fat malabsorption and the absence of evidence for other possible&#x000a0;causes.</p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Hepatic scan or ultrasonography to assess changes of fatty liver</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging (MRI) of the spinocerebellar region may show degeneration</p>
          </list-item>
          <list-item>
            <p>Eye and retinal examination and imaging to check for retinal damage</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17033.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Dietary Manipulation<xref ref-type="bibr" rid="article-17033.r9">[9]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Strict restriction of long-chain fatty acids</p>
          </list-item>
        </list>
        <p>Vitamin Supplementation</p>
        <list list-type="bullet">
          <list-item>
            <p>Very large doses of oral vitamin E</p>
          </list-item>
          <list-item>
            <p>Vitamin A supplementation is instituted if an elevated prothrombin time suggests vitamin K depletion.</p>
          </list-item>
        </list>
        <p>Physiotherapy</p>
        <p>Occupational Therapy</p>
      </sec>
      <sec id="article-17033.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Chronic cholestatic liver disease</p>
          </list-item>
          <list-item>
            <p>Combined neuropathy and ataxia</p>
          </list-item>
          <list-item>
            <p>Familial vitamin E deficiency</p>
          </list-item>
          <list-item>
            <p>Hereditary sensorimotor neuropathies&#x000b7;</p>
          </list-item>
          <list-item>
            <p>Retinal degeneration</p>
          </list-item>
          <list-item>
            <p>Secondary cancers</p>
          </list-item>
          <list-item>
            <p>Spinocerebellar disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17033.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>
<bold>Prognostic Factors</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Age at diagnosis</p>
          </list-item>
          <list-item>
            <p>The onset of treatment with a low-fat diet and vitamin replacement therapy</p>
          </list-item>
          <list-item>
            <p>Type of&#x000a0;<italic toggle="yes">MTP&#x000a0;</italic>mutation and&#x000a0;<italic toggle="yes">APOE&#x000a0;</italic>genotype with the long-term outcome of patients with abetalipoproteinemia</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17033.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Abetalipoproteinemia is a relatively rare genetic and acquired disorder that is characterized by acanthocytic red blood cells, fat malabsorption, spinocerebellar degeneration, and pigmented retinopathy. The condition is associated with very high morbidity, and thus it is vital to have an integrated pathway of management with close interaction with a number of health professionals. Besides a gastroenterologist, an interprofessional approach is essential if one is to improve outcomes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ophthalmologist to regularly assess for retinal degeneration and ophthalmoplegia</p>
          </list-item>
          <list-item>
            <p>Internist to assess the cholesterol profile and the abetalipoproteinemia.</p>
          </list-item>
          <list-item>
            <p>Neurologist: to assess and monitor the patient for spinocerebellar degeneration</p>
          </list-item>
          <list-item>
            <p>Hematologist to assess the anemia and acanthocytosis</p>
          </list-item>
          <list-item>
            <p>Pharmacist to determine the need for pyridoxine and total parenteral nutrition or supplementation with vitamins</p>
          </list-item>
          <list-item>
            <p>Dietitian to assess the patient for failure to thrive, assess malabsorption of fat-soluble vitamins, and the need to change diet</p>
          </list-item>
          <list-item>
            <p>Genetic counseling for patients and their first-degree relatives</p>
          </list-item>
          <list-item>
            <p>Social worker and nurse to assess the patients for nutritional needs, failure to thrive, and referral to a specialist.</p>
          </list-item>
        </list>
        <p>
<bold>Evidence-based Medicine</bold>
</p>
        <p>Because of the rarity of the disorder, there is a lack of randomized clinical trials on the long-term benefits of vitamins. However, small case series and anecdotal reports indicate that when patients are diagnosed and referred early to a clinic that specializes in the management of this lipid disorder, the outcomes are improved.<xref ref-type="bibr" rid="article-17033.r10">[10]</xref> There is ample evidence indicating that prompt supplementation with vitamins can improve the prognosis and outcome.<xref ref-type="bibr" rid="article-17033.r11">[11]</xref>&#x000a0;[Level 3] However, the long-term outlook for many of these patients is guarded as many go on to&#x000a0;develop vision loss and permanent blindness.</p>
      </sec>
      <sec id="article-17033.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17033&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17033">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/abetalipoproteinemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17033">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17033/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17033">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17033.s14">
        <fig id="article-17033.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Acanthocytes found in the peripheral blood smear of abetalolipoproteinemia patients. Contributed by Ed Uthman</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG_20180123_131423" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17033.s15">
        <title>References</title>
        <ref id="article-17033.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boltshauser</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>Laboratory investigations.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2018</year>
            <volume>154</volume>
            <fpage>287</fpage>
            <page-range>287-298</page-range>
            <pub-id pub-id-type="pmid">29903445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mushtaq</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheema</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Waheed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hashmi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Causes Of Chronic Non-Infectious Diarrhoea In Infants Less Than 6 Months Of Age: Rarely Recognized Entities.</article-title>
            <source>J Ayub Med Coll Abbottabad</source>
            <year>2017</year>
            <season>Jan-Mar</season>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>78</fpage>
            <page-range>78-82</page-range>
            <pub-id pub-id-type="pmid">28712180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strain</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Vigilante</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>DiGeorge</surname>
                <given-names>NW</given-names>
              </name>
            </person-group>
            <article-title>Hypolipidemia in a Special Operations Candidate: Case Report and Review of the Literature.</article-title>
            <source>J Spec Oper Med</source>
            <year>2015</year>
            <season>Winter</season>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">26630090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hentati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>El-Euch</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bouhlal</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Amouri</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Ataxia with vitamin E deficiency and abetalipoproteinemia.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2012</year>
            <volume>103</volume>
            <fpage>295</fpage>
            <page-range>295-305</page-range>
            <pub-id pub-id-type="pmid">21827896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>McIntyre</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Hegele</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Complex genetic architecture in severe hypobetalipoproteinemia.</article-title>
            <source>Lipids Health Dis</source>
            <year>2018</year>
            <month>Mar</month>
            <day>14</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <pub-id pub-id-type="pmid">29540175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramasamy</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Update on the molecular biology of dyslipidemias.</article-title>
            <source>Clin Chim Acta</source>
            <year>2016</year>
            <month>Feb</month>
            <day>15</day>
            <volume>454</volume>
            <fpage>143</fpage>
            <page-range>143-85</page-range>
            <pub-id pub-id-type="pmid">26546829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yilmaz</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Mungan</surname>
                <given-names>NO</given-names>
              </name>
              <name>
                <surname>Di Leo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Magnolo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Artuso</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bernardis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tumgor</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kor</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tarugi</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.</article-title>
            <source>Clin Chim Acta</source>
            <year>2016</year>
            <month>Jan</month>
            <day>15</day>
            <volume>452</volume>
            <fpage>185</fpage>
            <page-range>185-90</page-range>
            <pub-id pub-id-type="pmid">26612772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Walsh</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Iqbal</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Josekutty</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Soh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Di Leo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>&#x000d6;zaydin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>G&#x000fc;nd&#x000fc;z</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarugi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hussain</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal &#x003b2;-Barrel in Microsomal Triglyceride Transfer Protein Function.</article-title>
            <source>Circ Cardiovasc Genet</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>677</fpage>
            <page-range>677-87</page-range>
            <pub-id pub-id-type="pmid">26224785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cuerq</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Henin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Restier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blond</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Drai</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mar&#x000e7;ais</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Di Filippo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laveille</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Michalski</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Poinsot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Caussy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sassolas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moulin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Reboul</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Charriere</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lachaux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Peretti</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.</article-title>
            <source>J Lipid Res</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>59</volume>
            <issue>9</issue>
            <fpage>1640</fpage>
            <page-range>1640-1648</page-range>
            <pub-id pub-id-type="pmid">30021760</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaudet</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>MacKenzie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GN</given-names>
              </name>
            </person-group>
            <article-title>Fat-soluble vitamin deficiency in pregnancy: a case report and review of abetalipoproteinemia.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2006</year>
            <month>Aug</month>
            <volume>28</volume>
            <issue>8</issue>
            <fpage>716</fpage>
            <page-range>716-719</page-range>
            <pub-id pub-id-type="pmid">17022912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17033.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chardon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sassolas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dingeon</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Michel-Calemard</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bovier-Lapierre</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Moulin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lachaux</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases.</article-title>
            <source>Eur J Pediatr</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>168</volume>
            <issue>8</issue>
            <fpage>983</fpage>
            <page-range>983-9</page-range>
            <pub-id pub-id-type="pmid">19066957</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
